SUN PHARMA ADVANCED RESEARCH COMPANY
|
SUN PHARMA ADVANCED RESEARCH COMPANY Last 5 Year Balance Sheet History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|
| EQUITY AND LIABILITIES | |||
| Share Capital | ₹32 Cr | ₹32 Cr | ₹32 Cr |
| Equity - Authorised | ₹43 Cr | ₹43 Cr | ₹43 Cr |
| Equity - Issued | ₹32 Cr | ₹32 Cr | ₹32 Cr |
| Equity Paid Up | ₹32 Cr | ₹32 Cr | ₹32 Cr |
| Equity Shares Forfeited | - | - | - |
| Adjustments to Equity | - | - | - |
| Preference Capital Paid Up | - | - | - |
| Face Value | ₹1.00 | ₹1.00 | ₹1.00 |
| Share Warrants & Outstandings | - | - | - |
| Total Reserves | ₹-249 Cr | ₹93 Cr | ₹480 Cr |
| Securities Premium | ₹2,038 Cr | ₹2,038 Cr | ₹2,038 Cr |
| Capital Reserves | - | - | - |
| Profit & Loss Account Balance | ₹-2,322 Cr | ₹-1,979 Cr | ₹-1,592 Cr |
| General Reserves | ₹34 Cr | ₹34 Cr | ₹34 Cr |
| Other Reserves | ₹0.07 Cr | ₹0.01 Cr | - |
| Reserve excluding Revaluation Reserve | ₹-249 Cr | ₹93 Cr | ₹480 Cr |
| Revaluation reserve | - | - | - |
| Shareholder's Funds | ₹-217 Cr | ₹126 Cr | ₹513 Cr |
| Minority Interest | - | - | - |
| Long-Term Borrowings | - | - | - |
| Secured Loans | - | - | - |
| Non Convertible Debentures | - | - | - |
| Converible Debentures & Bonds | - | - | - |
| Packing Credit - Bank | - | - | - |
| Inter Corporate & Security Deposit | - | - | - |
| Term Loans - Banks | - | - | - |
| Term Loans - Institutions | - | - | - |
| Other Secured | - | - | - |
| Unsecured Loans | ₹100 Cr | - | - |
| Fixed Deposits - Public | - | - | - |
| Loans and advances from subsidiaries | - | - | - |
| Inter Corporate Deposits (Unsecured) | - | - | - |
| Foreign Currency Convertible Notes | - | - | - |
| Long Term Loan in Foreign Currency | - | - | - |
| Loans - Banks | - | - | - |
| Loans - Govt. | - | - | - |
| Loans - Others | - | - | - |
| Other Unsecured Loan | ₹100 Cr | - | - |
| Deferred Tax Assets / Liabilities | ₹-2.31 Cr | ₹-1.26 Cr | - |
| Deferred Tax Assets | ₹30 Cr | ₹30 Cr | ₹28 Cr |
| Deferred Tax Liability | ₹28 Cr | ₹28 Cr | ₹28 Cr |
| Other Long Term Liabilities | ₹71 Cr | ₹118 Cr | ₹130 Cr |
| Long Term Trade Payables | - | - | - |
| Long Term Provisions | ₹7.68 Cr | ₹6.05 Cr | ₹8.14 Cr |
| Total Non-Current Liabilities | ₹176 Cr | ₹123 Cr | ₹138 Cr |
| Current Liabilities | - | - | - |
| Trade Payables | ₹114 Cr | ₹142 Cr | ₹148 Cr |
| Sundry Creditors | ₹114 Cr | ₹142 Cr | ₹148 Cr |
| Acceptances | - | - | - |
| Due to Subsidiaries- Trade Payables | - | - | - |
| Other Current Liabilities | ₹94 Cr | ₹62 Cr | ₹24 Cr |
| Bank Overdraft / Short term credit | - | - | - |
| Advances received from customers | ₹0.00 Cr | - | ₹0.00 Cr |
| Interest Accrued But Not Due | ₹0.61 Cr | ₹0.07 Cr | - |
| Share Application Money | - | - | ₹0.00 Cr |
| Current maturity of Debentures & Bonds | - | - | - |
| Current maturity - Others | - | - | - |
| Other Liabilities | ₹94 Cr | ₹62 Cr | ₹24 Cr |
| Short Term Borrowings | ₹158 Cr | ₹47 Cr | ₹0.05 Cr |
| Secured ST Loans repayable on Demands | ₹158 Cr | ₹47 Cr | ₹0.05 Cr |
| Working Capital Loans- Sec | ₹158 Cr | ₹47 Cr | ₹0.05 Cr |
| Buyers Credits - Unsec | - | - | - |
| Commercial Borrowings- Unsec | - | - | - |
| Other Unsecured Loans | ₹-158 Cr | ₹-47 Cr | ₹-0.05 Cr |
| Short Term Provisions | ₹7.89 Cr | ₹14 Cr | ₹6.49 Cr |
| Proposed Equity Dividend | - | - | - |
| Provision for Corporate Dividend Tax | - | - | - |
| Provision for Tax | ₹0.44 Cr | ₹1.65 Cr | - |
| Provision for post retirement benefits | - | - | - |
| Preference Dividend | - | - | - |
| Other Provisions | ₹7.45 Cr | ₹12 Cr | ₹6.49 Cr |
| Total Current Liabilities | ₹374 Cr | ₹265 Cr | ₹179 Cr |
| Total Liabilities | ₹333 Cr | ₹514 Cr | ₹830 Cr |
| ASSETS | |||
| Gross Block | ₹158 Cr | ₹157 Cr | ₹146 Cr |
| Less: Accumulated Depreciation | ₹59 Cr | ₹50 Cr | ₹40 Cr |
| Less: Impairment of Assets | - | - | - |
| Net Block | ₹99 Cr | ₹108 Cr | ₹106 Cr |
| Lease Adjustment A/c | - | - | - |
| Capital Work in Progress | ₹0.56 Cr | ₹1.27 Cr | ₹1.87 Cr |
| Non Current Investments | - | - | - |
| Long Term Investment | - | - | - |
| Quoted | - | - | - |
| Unquoted | - | - | - |
| Long Term Loans & Advances | ₹128 Cr | ₹68 Cr | ₹65 Cr |
| Other Non Current Assets | ₹26 Cr | ₹25 Cr | ₹178 Cr |
| Total Non-Current Assets | ₹307 Cr | ₹244 Cr | ₹375 Cr |
| Current Assets Loans & Advances | - | - | - |
| Currents Investments | - | ₹1.80 Cr | ₹291 Cr |
| Quoted | - | ₹1.80 Cr | ₹96 Cr |
| Unquoted | - | - | ₹195 Cr |
| Inventories | - | - | - |
| Raw Materials | - | - | - |
| Work-in Progress | - | - | - |
| Finished Goods | - | - | - |
| Packing Materials | - | - | - |
| Stores  and Spare | - | - | - |
| Other Inventory | - | - | - |
| Sundry Debtors | ₹16 Cr | ₹16 Cr | ₹33 Cr |
| Debtors more than Six months | ₹6.32 Cr | ₹6.55 Cr | - |
| Debtors Others | ₹12 Cr | ₹11 Cr | ₹33 Cr |
| Cash and Bank | ₹1.96 Cr | ₹155 Cr | ₹112 Cr |
| Cash in hand | ₹0.00 Cr | ₹0.00 Cr | ₹0.00 Cr |
| Balances at Bank | ₹1.96 Cr | ₹155 Cr | ₹112 Cr |
| Other cash and bank balances | - | - | - |
| Other Current Assets | ₹4.20 Cr | ₹42 Cr | ₹3.98 Cr |
| Interest accrued on Investments | - | ₹14 Cr | ₹0.63 Cr |
| Interest accrued on Debentures | - | - | - |
| Deposits with Government | - | - | - |
| Interest accrued and or due on loans | - | - | - |
| Prepaid Expenses | ₹3.60 Cr | ₹4.82 Cr | ₹3.33 Cr |
| Other current_assets | ₹0.60 Cr | ₹23 Cr | ₹0.02 Cr |
| Short Term Loans and Advances | ₹3.98 Cr | ₹54 Cr | ₹16 Cr |
| Advances recoverable in cash or in kind | ₹1.95 Cr | ₹4.35 Cr | ₹4.58 Cr |
| Advance income tax and TDS | - | - | - |
| Amounts due from directors | - | - | - |
| Due From Subsidiaries | - | - | - |
| Inter corporate deposits | - | - | - |
| Corporate Deposits | - | - | - |
| Other Loans & Advances | ₹2.03 Cr | ₹50 Cr | ₹11 Cr |
| Total Current Assets | ₹26 Cr | ₹269 Cr | ₹455 Cr |
| Net Current Assets (Including Current Investments) | ₹-348 Cr | ₹4.33 Cr | ₹276 Cr |
| Miscellaneous Expenses not written off | - | - | - |
| Total Assets | ₹333 Cr | ₹514 Cr | ₹830 Cr |
| Contingent Liabilities | ₹51 Cr | ₹84 Cr | ₹84 Cr |
| Total Debt | ₹258 Cr | ₹47 Cr | ₹0.05 Cr |
| Book Value | - | 3.88 | 15.80 |
| Adjusted Book Value | -6.69 | 3.88 | 15.80 |
Compare Balance Sheet of peers of SUN PHARMA ADVANCED RESEARCH COMPANY
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMA ADVANCED RESEARCH COMPANY | ₹4,361.3 Cr | 0.6% | -2.5% | -35.7% | Stock Analytics | |
| SYNGENE INTERNATIONAL | ₹26,144.7 Cr | 1.4% | -1.6% | -29.7% | Stock Analytics | |
| SAGILITY INDIA | ₹23,425.4 Cr | 1.2% | -1.7% | 58.2% | Stock Analytics | |
| LATENT VIEW ANALYTICS | ₹10,294.9 Cr | 3% | 18.9% | 9.1% | Stock Analytics | |
| JUST DIAL | ₹6,269.1 Cr | -1.6% | -6.5% | -34% | Stock Analytics | |
| AWFIS SPACE SOLUTIONS | ₹3,835.0 Cr | -0.1% | -11.2% | -24.2% | Stock Analytics | |
SUN PHARMA ADVANCED RESEARCH COMPANY Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMA ADVANCED RESEARCH COMPANY | 0.6% |
-2.5% |
-35.7% |
| SENSEX | 0.6% |
1.3% |
7% |
You may also like the below Video Courses